As the country prepares to roll out the AstraZeneca vaccine, Head of South Africa's Vaccine Committee, Professor Barry Schoub, says they may consider suspending the use of the jab. That's after a Wits University study found that the vaccine appears to be less effective against the SA COVID-19 variant.